Dear BioPharmX Shareholders, I would like to introduce myself as the new CEO of BioPharmX. I was recruited by the Board of Directors because of my...
We are growing our drug delivery platform portfolio to uncover innovative solutions in dermatology.
Our proprietary topical drug delivery system uses an anhydrous, hydrophilic technology that is suitable for multiple APIs.
Our stock is listed on the NYSE American under the ticker symbol BPMX. View our latest investor presentation.